Literature DB >> 8823282

Tumor volume and local control probability: clinical data and radiobiological interpretations.

S M Bentzen1, H D Thames.   

Abstract

PURPOSE: It is well established for certain human tumor histologies that increasing tumor volume leads to a decreasing probability of tumor control. The simplest explanation for these findings is that the number of tumor clonogens that must be sterilized to control a tumor increases with tumor volume. In this investigation we consider whether clinical evidence favors a further hypothesis, namely, that clonogen number increases in direct proportion to tumor volume. METHODS AND MATERIALS: Previously published data on the volume-cure relationship for breast tumors, neck nodes, malignant melanoma, and squamous cell carcinomas of the oropharynx and the uterine cervix were analyzed.
RESULTS: We found in all these data sets evidence that the effect of tumor volume on tumor control probability was less than what would be expected under the assumption of proportionality between number of clonogens and volume. We describe good reasons to believe that this is the result of patient-to-patient variability in radiocurability, and possibly other factors as well.
CONCLUSIONS: Clinical data do provide evidence for a highly significant reduction of tumor control probability with increasing tumor volume. However, because of heterogeneity in patient and tumor characteristics, the volume effect is less pronounced than would be expected from a simple proportionality between number of clonogens and volume. In principle this simple proportionality does hold in individual patients, so that standard approaches for treatment plan optimization in individuals may still be valid.

Entities:  

Mesh:

Year:  1996        PMID: 8823282     DOI: 10.1016/s0360-3016(96)00242-8

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  22 in total

1.  Dosimetric and radiobiological comparison of helical tomotherapy, forward-planned intensity-modulated radiotherapy and two-phase conformal plans for radical radiotherapy treatment of head and neck squamous cell carcinomas.

Authors:  S Chatterjee; N Willis; S M Locks; J H Mott; C G Kelly
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

2.  On the radiobiological impact of metal artifacts in head-and-neck IMRT in terms of tumor control probability (TCP) and normal tissue complication probability (NTCP).

Authors:  Yusung Kim; Wolfgang A Tomé
Journal:  Med Biol Eng Comput       Date:  2007-06-16       Impact factor: 2.602

3.  Prognostic value of tumor volume for patients with nasopharyngeal carcinoma treated with concurrent chemotherapy and intensity-modulated radiotherapy.

Authors:  Zheng Wu; Yong Su; Rui-Fang Zeng; Mo-Fa Gu; Shao-Min Huang
Journal:  J Cancer Res Clin Oncol       Date:  2013-10-31       Impact factor: 4.553

4.  Hypofractionated stereotactic radiotherapy for oligometastatic patients: developing of a response predictive model.

Authors:  Barbara Diletto; Nicola Dinapoli; Silvia Chiesa; Gian Carlo Mattiucci; Vincenzo Frascino; Carmelo Anile; Cesare Colosimo; Vincenzo Valentini; Mario Balducci
Journal:  Med Oncol       Date:  2018-09-14       Impact factor: 3.064

5.  The effect of time between diagnosis and initiation of treatment on outcomes in patients with head and neck squamous cell carcinoma.

Authors:  Luke H DeGraaff; Alexis J Platek; Austin J Iovoli; Kimberly E Wooten; Hassan Arshad; Vishal Gupta; Ryan P McSpadden; Moni Abraham Kuriakose; Wesley L Hicks; Mary E Platek; Anurag K Singh
Journal:  Oral Oncol       Date:  2019-07-30       Impact factor: 5.337

6.  Potential clinical predictors of outcome after postoperative radiotherapy of non-small cell lung cancer.

Authors:  R Bütof; K Kirchner; S Appold; S Löck; A Rolle; G Höffken; M Krause; M Baumann
Journal:  Strahlenther Onkol       Date:  2014-01-12       Impact factor: 3.621

7.  Impact of initial tumor volume on radiotherapy outcome in patients with T2 glottic cancer.

Authors:  T Rutkowski
Journal:  Strahlenther Onkol       Date:  2014-03-04       Impact factor: 3.621

8.  Predictive value of modelled tumour control probability based on individual measurements of in vitro radiosensitivity and potential doubling time.

Authors:  M Hedman; T Björk-Eriksson; O Brodin; I Toma-Dasu
Journal:  Br J Radiol       Date:  2013-03-11       Impact factor: 3.039

9.  Identification of a predictive factor for distant metastasis in esophageal squamous cell carcinoma after definitive chemoradiotherapy.

Authors:  Katsuyuki Sakanaka; Yuichi Ishida; Satoshi Itasaka; Yasumasa Ezoe; Ikuo Aoyama; Shinichi Miyamoto; Takahiro Horimatsu; Manabu Muto; Masahiro Hiraoka
Journal:  Int J Clin Oncol       Date:  2016-03-02       Impact factor: 3.402

10.  Prognostic role of tumor volume for radiotherapy outcome in patient with T2 laryngeal cancer.

Authors:  T Rutkowski; A Wygoda; K Składowski; B Hejduk; R Rutkowski; Z Kołosza; B Maciejewski
Journal:  Strahlenther Onkol       Date:  2013-08-29       Impact factor: 3.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.